Daniel T. Huberman

Endocrinology

1 Springfield Avenue
Suite 1A
Summit, NJ 07901

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.

Journal: Breast cancer research : BCR

Published: November 11, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026